Caris Life Sciences’ scientific experts and external collaborators are contributing to major advances in the understanding of blood-based circulating microvesicles (cMV) and their potential utility to aid in the diagnosis, prognosis, and theranosis of cancer and other complex diseases. Posters and abstracts highlighting the promise of ADAPT Biotargeting System™ are listed below.